Quarterly report pursuant to Section 13 or 15(d)

The Company and its significant accounting policies (Details Narrative)

v3.22.2.2
The Company and its significant accounting policies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 15, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]            
Date of incorporation       Aug. 05, 1999    
Stockholders equity reverse stock split 1-for-10          
Cash and cash equivalents, at carrying value   $ 15,474   $ 15,474   $ 11,233
Selling common stock       14,414 $ 9,046  
Assets, current   39,177   39,177   35,687
Liabilities, current   23,813   23,813   $ 20,985
Net income (loss) attributable to parent   1,608 $ 10,939 13,045 26,905  
Research and development expense   (135) $ 5,492 $ 6,754 $ 13,826  
Decrease in research and development expense   1,050        
Previously Reported [Member]            
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]            
Research and development expense   $ 1,050